1. Human Primary Epithelial Cells Acquire an Epithelial-Mesenchymal-Transition Phenotype during Long-Term Infection by the Oral Opportunistic Pathogen, Porphyromonas gingivalis
    Jungnam Lee et al, 2017, Front. Cell. Infect. Microbiol. CrossRef
  2. Adaptive Responses to Monotherapy in Head and Neck Cancer: Interventions for Rationale-Based Therapeutic Combinations
    Sankar Jagadeeshan et al, 2019, Trends in Cancer CrossRef
  3. Mechanochemical Signaling of the Extracellular Matrix in Epithelial-Mesenchymal Transition
    Lewis E. Scott et al, 2019, Front. Cell Dev. Biol. CrossRef
  4. Histometabolic Tumor Imaging of Hypoxia in Oral Cancer: Clinicopathological Correlation for Prediction of an Aggressive Phenotype
    Grégoire B. Morand et al, 2020, Front. Oncol. CrossRef
  5. Hypothesizing the potential role of melatonin in inhibiting epithelial to mesenchymal transition in oral squamous cell carcinoma
    Thodur Madapusi Balaji et al, 2020, Medical Hypotheses CrossRef
  6. YKT6, as a potential predictor of prognosis and immunotherapy response for oral squamous cell carcinoma, is related to cell invasion, metastasis, and CD8+ T cell infiltration
    Zongcheng Yang et al, 2021, OncoImmunology CrossRef
  7. Prognostic and predictive markers for perineural and bone invasion of oral squamous cell carcinoma
    Jaroslav Michalekª et al, 2019, Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub CrossRef
  8. Effects of TGF-β on Growth and Invasion of Human Oral Squamous Cell Carcinoma Cell Lines
    Hitoe Ishiguro-Katsuta et al, 2022, J. hard tissue biol. CrossRef
  9. Is Epithelial-Mesenchymal Transition a New Roadway in the Pathogenesis of Oral Submucous Fibrosis: A Comprehensive Review
    Abikshyeet Panda et al, 2022 CrossRef
  10. Pan-cancer analysis identifies NT5E as a novel prognostic biomarker on cancer-associated fibroblasts associated with unique tumor microenvironment
    Xin-miao Xue et al, 2022, Front. Pharmacol. CrossRef
  11. EMP3 as a prognostic biomarker correlates with EMT in GBM
    Li Li et al, 2024, BMC Cancer CrossRef